Baganday, Linlin D.
HRN: 27-74-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/06/2025
09/12/2025
IV
4.5g
Q6
Complicated UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines